Workshop on Developing Investor-Ready Strategies

This interactive session is designed to equip leaders of emerging biotechs with the strategic insights they need to accelerate development, avoid common early-stage pitfalls, and increase the likelihood of successfully bringing transformative therapies to market. Participants will explore best practices for building a robust development strategy, strengthening investor confidence, and navigating the scientific, regulatory, and operational challenges that often derail promising programs.

What you’ll gain by attending:

• Investor perspective: Hear directly from investors and industry leaders about current trends, common pitfalls, and what they look for when funding early-stage biotech.
• Smarter candidate selection: Learn how to evaluate therapeutic potential and choose the right clinical candidate to advance with confidence.
• De-risked development planning: Discover how to design a roadmap that integrates science, regulatory pathways, and commercial viability, building credibility with partners and investors.
• Cross-functional insights: Engage in a panel discussion with experts from biotech, pharma, venture capital, and Certara to understand how early decisions shape long-term success.
• Direct access to experts: Participate in interactive networking sessions where you can meet specialists in modeling and simulation, clinical pharmacology, toxicology, regulatory, and commercial strategy to discuss your specific challenges.

Whether you’re a biotech company preparing to pitch investors, a venture group evaluating opportunities, or an R&D leader looking to accelerate development, this workshop will equip you with actionable insights, real-world examples, and direct access to experts who can help you design a strategy that inspires confidence and drives success.